Table 3.
Baseline characteristics and absolute values at 0 months.
| Variable | AGE | Placebo | p | ||
|---|---|---|---|---|---|
| n = 14 | SD | n = 15 | SD | ||
| BMI | 28.3 | (5) | 27.8 | (5.1) | 0.80 |
| Systolic BP (mmHg) | 145.6 | (15) | 146.9 | (17.4) | 0.59 |
| Diastolic BP (mmHg) | 83.1 | (15.6) | 87.8 | (10.4) | 0.68 |
| Triglycerides (mmol/L) | 1.2 | (0.6) | 2.2 | (3.4) | 0.22 |
| Cholesterol (mmol/L) | 6.0 | (1.3) | 6.0 | (0.9) | 0.88 |
| HDL (mmol/L) | 1.7 | (0.6) | 1.9 | (0.4) | 0.66 |
| LDL (mmol/L) | 4.1 | (1.4) | 3.7 | (1.1) | 0.60 |
| CRP (mg/L) | 3.0 | (2.7) | 1.6 | (2.1) | 0.93 |
| ApoB/ApoA1 | 0.7 | (0.3) | 0.6 | (0.2) | 0.34 |
| Homocysteine µmol/L | 12.6 | (3.2) | 12.1 | (2.7) | 0.55 |
| Glucose (mmol/L) | 6.2 | (1) | 6.3 | (1.2) | 0.76 |
| Interleukin-6 (ng/L) | 4.8 | (2.7) | 4.2 | (2.4) | 0.537 |
SD, standard deviation; Apo B/ApoA1, apolipoprotein B (mmol/L)/apolipoprotein A1 (mmol/L); BMI, body mass index (kg/m2).